Announcements Trials
Browse Landscape

Status

Unknown 2Recruiting 2

Sponsor Class

OTHER 4

Study Type

Observational 4

Sponsor

Cancer Type

Thoracic 6Gastrointestinal 4Tumor-Agnostic 2Gynecologic 2CNS 1

Conditions

Carcinoma, Hepatocellular 3Stomach Neoplasms 1

Interventions

Oxaliplatin 1439Fluorouracil 1319Capecitabine 1114Gemcitabine 1057Leucovorin 939Bevacizumab 847Irinotecan 830Cisplatin 676Radiotherapy 560Cetuximab 482pembrolizumab 435Paclitaxel 401Drug Therapy 358Nivolumab 350130-nm albumin-bound paclitaxel 328Docetaxel 290Sorafenib 288S 1 (combination) 279Folfox protocol 266Albumin-Bound Paclitaxel 263Surgical Procedures, Operative 257lenvatinib 222sintilimab 218tislelizumab 214durvalumab 212regorafenib 209Magnetic Resonance Spectroscopy 205apatinib 204Radiosurgery 204Neoadjuvant Therapy 190

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Angiogenesis Inhibitors × Gastrointestinal × Clear all
NCT07389876 2026-02-05

G/GEJ

Fudan University

Recruiting
250 enrolled
Gastrointestinal

Stomach Neoplasms

NCT06777628 2025-01-16

Immunecheck

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Recruiting
100 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT06423144 2024-05-21

PD-1/PD-L1 Inhibitors and Anti-angiogenic Therapy Combined With/Without TACE/HAIC in Patients With BCLC B/C Hepatocellular Carcinoma Beyond Up-to-7

Shanghai Zhongshan Hospital

Unknown
150 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT04639284 2021-07-26

Anti-angiogenic Agents Plus Anti-PD-1 Antibodies for uHCC

Shanghai Zhongshan Hospital

Unknown
200 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡